Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04149288 · ClinicalTrials.gov registry record · NA
Olive Oil Polyphenols and Cardiovascular Health Biomarkers
A NA study of Healthy and Overweight, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04149288: Active NA study of Healthy and Overweight, sponsored by University of California, Davis.
NCT04149288 is a NA study of Healthy and Overweight that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 44 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04149288, a NA study of Healthy and Overweight, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression.
Primary Outcome
Cholesterol efflux will be measured by assessing changes in reverse cholesterol transport rate in separated serum at each study time point (baseline, 2 hour, 4 hour) using a commercially available assay kit at each of the 4 study visits.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High-polyphenol olive oil
- DIETARY_SUPPLEMENT Low-polyphenol olive oil
Study Locations (1)
California
- Ragle Human Nutrition Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2026-08-22 |
| Phase | NA |
What the registry record for NCT04149288 still lists
NCT04149288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which High-polyphenol olive oil is the first listed.
NCT04149288 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04149288 about?
NCT04149288 is a clinical study titled "Olive Oil Polyphenols and Cardiovascular Health Biomarkers". The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression.
What is the current status of trial NCT04149288?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2021-10-06. Estimated completion is 2026-08-22.
What conditions does trial NCT04149288 study?
This clinical trial studies the following conditions: Healthy, Overweight, Obese, Normal Weight.
What interventions are being tested in trial NCT04149288?
The interventions under investigation include: High-polyphenol olive oil (DIETARY_SUPPLEMENT), Low-polyphenol olive oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04149288?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04149288 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04149288's enrollment target sits among peer trials
44 506th of 1090 higher than 570 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI